Researchers Profluent Bio have developed Protein2PAM, a deep learning model that predicts and engineers the protospacer-adjacent motif (PAM)...
Genome-wide CRISPR screens in isogenic cell lines have identified synthetic lethal targets across 15 frequently altered cancer drivers, offering new...
Some of the best links we picked up around the internet
Just as the summer was creeping in, we hosted our most popular CMN webinar to date. The topic was CRISPR Off-Targets with speakers from academia and a...
Almost complete efficiency of gene knock-in is achieved with a new CRISPR-based system developed by researchers from AstraZeneca. The system also...
